MOAB Trial: Optimal Atezolizumab for rGBM (Recurrent Glioblastoma) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out if giving patients a drug called atezolizumab before and after surgery for recurrent glioblastoma can improve how their cancer responds.
What is the Condition Being Studied?
Recurrent Glioblastoma
Who Can Participate in the Study?
Adults ages 18+ who:
- Are diagnosed with glioblastoma (isocitrate dehydrogenase wildtype)
- Have a recurrence after treatment with radiation and temozolomide
- Plan to have surgery
Para obtener más información sobre quién puede participar en este estudio, comuníquese con el equipo del estudio al 919-684-5301.
Grupo etario
Adultos
What is Involved?
If you join the study, you will:
- Have a physical exam and other tests
- Have magnetic resonance imaging (MRI) scans of the brain
- Realizar extracciones de sangre
- Get atezolizumab before surgery
- Get atezolizumab after surgery
Study Details
Full Title
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
Principal Investigator
Especialista en oncología médica
Protocol Number
IRB:
PRO00113395
NCT:
NCT06069726
Phase
Phase
N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción
Participate
Call 919-684-5301